Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 5.95% is 77% below its 5-year average of 25.52%, near the low end of its 5-year range (5.95%–30.67%).
As of the fiscal period ended Thursday, April 30, 2026. 73.35% below its 12-month average of 22.34%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
5.95%
EBITDA MARGIN AVG TTM
22.34%
EBITDA MARGIN AVG 3Y
26.45%
EBITDA MARGIN AVG 5Y
26.49%
EBITDA MARGIN AVG 10Y
27.23%
EBITDA MARGIN AVG 15Y
27.01%
EBITDA MARGIN AVG 20Y
25.67%
CURRENT VS TTM AVG
-73.35%
CURRENT VS 3Y AVG
-77.49%
CURRENT VS 5Y AVG
-77.52%
CURRENT VS 10Y AVG
-78.13%
CURRENT VS 15Y AVG
-77.95%
CURRENT VS 20Y AVG
-76.80%
The Cooper Companies, Inc.
Market Cap
$14.05B
EBITDA Margin
5.95%
TTM Avg
22.34%
3Y Avg
26.45%
5Y Avg
26.49%
Market Cap
$14.92B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
Market Cap
$12.59B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$12.58B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$15.94B
EBITDA Margin
22.25%
TTM Avg
22.41%
3Y Avg
21.18%
5Y Avg
20.68%
Market Cap
$11.58B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.05B | 5.95% | 22.34% | 26.45% | 26.49% |
| Solventum Corporation (SOLV)vs › | $14.92B | 32.07% | 25.68% | 26.69% | 27.49% |
| DaVita Inc. (DVA)vs › | $15.37B | 19.98% | 20.97% | 19.78% | 20.10% |
| Baxter International Inc. (BAX)vs › | $12.59B | 5.99% | 7.75% | 3.55% | 8.89% |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 19.75% | 19.29% | 19.87% | 21.06% |
| Revvity, Inc. (RVTY)vs › | $12.44B | 23.07% | 26.75% | 30.05% | 32.80% |
| Medpace Holdings, Inc. (MEDP)vs › | $15.94B | 22.25% | 22.41% | 21.18% | 20.68% |
| Insulet Corp. (PODD)vs › | $11.60B | 21.67% | 20.24% | 16.36% | 15.66% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | 22.69% | 18.62% | 20.95% | 21.80% |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 17.40% | 22.43% | 29.14% | 30.66% |
Gross Margin
64.4%
EBITDA Margin
6.0%
Operating Margin
11.8%
Net Margin
5.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-04-30 | 5.95% |
| 2026-01-31 | 30.10% |
| 2025-10-31 | 22.42% |
| 2025-07-31 | 25.57% |
| 2025-04-30 | 27.68% |
| 2025-01-31 | 28.30% |
| 2024-10-31 | 28.42% |
| 2024-07-31 | 28.07% |
| 2024-04-30 | 27.58% |
| 2024-01-31 | 26.82% |
| 2023-10-31 | 24.64% |
| 2023-07-31 | 26.46% |
| 2023-04-30 | 21.32% |
| 2023-01-31 | 27.86% |
| 2022-10-31 | 22.70% |
| 2022-07-31 | 26.36% |
| 2022-04-30 | 27.25% |
| 2022-01-31 | 27.03% |
| 2021-10-31 | 27.12% |
| 2021-07-31 | 23.51% |
| 2021-04-30 | 30.67% |
| 2021-01-31 | 30.70% |
| 2020-10-31 | 26.00% |
| 2020-07-31 | 24.66% |
| 2020-04-30 | 18.56% |
| 2020-01-31 | 28.12% |
| 2019-10-31 | 31.41% |
| 2019-07-31 | 31.34% |
| 2019-04-30 | 33.26% |
| 2019-01-31 | 28.61% |
| 2018-10-31 | 29.65% |
| 2018-07-31 | 27.97% |
| 2018-04-30 | 22.76% |
| 2018-01-31 | 26.58% |
| 2017-10-31 | 27.73% |
| 2017-07-31 | 28.78% |
| 2017-04-30 | 31.26% |
| 2017-01-31 | 27.75% |
| 2016-10-31 | 23.43% |
| 2016-07-31 | 29.57% |
| 2016-04-30 | 28.46% |
| 2016-01-31 | 24.66% |
| 2015-10-31 | 20.27% |
| 2015-07-31 | 22.57% |
| 2015-04-30 | 26.57% |
| 2015-01-31 | 26.06% |
| 2014-10-31 | 17.51% |
| 2014-07-31 | 29.84% |
| 2014-04-30 | 29.27% |
| 2014-01-31 | 27.91% |
| 2013-10-31 | 22.78% |
| 2013-07-31 | 30.27% |
| 2013-04-30 | 29.27% |
| 2013-01-31 | 26.42% |
| 2012-10-31 | 27.71% |
| 2012-07-31 | 27.78% |
| 2012-04-30 | 26.75% |
| 2012-01-31 | 26.85% |
| 2011-10-31 | 25.76% |
| 2011-07-31 | 22.02% |
| 2011-04-30 | 25.75% |
| 2011-01-31 | 24.42% |
| 2010-10-31 | 27.36% |
| 2010-07-31 | 25.47% |
| 2010-04-30 | 21.79% |
| 2010-01-31 | 23.01% |
| 2009-10-31 | 23.48% |
| 2009-07-31 | 19.60% |
| 2009-04-30 | 23.87% |
| 2009-01-31 | 23.01% |
| 2008-10-31 | 25.03% |
| 2008-07-31 | 18.30% |
| 2008-04-30 | 18.78% |
| 2008-01-31 | 16.35% |
| 2007-10-31 | 9.76% |
| 2007-07-31 | 18.41% |
| 2007-04-30 | 12.15% |
| 2007-01-31 | 14.51% |
| 2006-10-31 | 18.07% |
| 2006-07-31 | 21.28% |
| 2006-04-30 | 122.79% |
| 2006-01-31 | 23.28% |
| 2005-10-31 | 17.27% |
| 2005-07-31 | 26.83% |
| 2005-04-30 | 24.85% |
| 2005-01-31 | 23.53% |
| 2004-10-31 | 27.91% |
| 2004-07-31 | 27.65% |
| 2004-04-30 | 26.35% |
| 2004-01-31 | 25.92% |
| 2003-10-31 | 28.66% |
| 2003-07-31 | 26.25% |
| 2003-04-30 | 25.04% |
| 2003-01-31 | 24.24% |
| 2002-10-31 | 26.48% |
| 2002-07-31 | 22.44% |
